{
  "ticker": "ERD",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02973518",
  "id": "02973518",
  "pages": 9,
  "price_sensitive": false,
  "date": "20250729",
  "time": "0730",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250729/pdf/06m7c76f842y6d.pdf",
  "summary": "### **Capital Change Notice Summary**  \n**Issuer**: EROAD Limited (NZX: ERD)  \n**Class**: Performance Share Rights (PSRs) convertible to ordinary shares  \n\n#### **Key Details**:  \n- **Total PSRs Issued**:  \n  - **FY24 Grant**: 127,828 PSRs (4.12% of total PSR class).  \n  - **FY25 Grant**: 2,039,249 PSRs (63.07% of total PSR class).  \n- **Exercise Price**: $0 (no cash payment required).  \n- **Vesting Terms**:  \n  - **Tranche 1**: Vesting subject to continued employment until 31 March 2026 (FY24 Grant) / 2027 (FY25 Grant).  \n  - **Tranche 2**: Performance-based (TSR vs. S&P/ASX All Technology Index), vesting 50%-200% depending on percentile ranking.  \n  - **Tranche 3**: Financial performance metrics (revenue, EBIT, FCF) vs. 3-year budget (85%-130% vesting).  \n- **Total PSRs Outstanding**: 5,272,563 (as of FY25 Grant).  \n\n#### **Material Impact**:  \n- Potential dilution from **up to 5.27M new shares** upon PSR vesting (subject to performance conditions).  \n- No treasury shares held; all PSRs are unquoted and non-transferrable.  \n\n**Date of Issue**: 28 July 2025 (for both grants).  \n\n*Summary excludes boilerplate and non-material legal terms.*  \n\n---  \n**Note**: No capital raising or trading halt involved; focus is on equity dilution risk from LTI grants.",
  "usage": {
    "prompt_tokens": 3487,
    "completion_tokens": 371,
    "total_tokens": 3858,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-28T21:57:36.300203"
}